Roscoe O. Brady

Affiliations: 
National Institutes of Health, Bethesda, MD 
Area:
hereditary metabolic disorders
Website:
http://www.ninds.nih.gov/news_and_events/news_articles/pressrelease_20081006_Brady.htm
Google:
"Roscoe O. Brady"
Bio:

http://www.nasonline.org/member-directory/members/57455.html

Mean distance: 14.79 (cluster 11)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mooney JJ, Brady RO. (2017) Lithium + Colchicine: A Potential Strategy to Reduce Pro-inflammatory Effects of Lithium Treatment. Journal of Clinical Psychopharmacology
Yang C, Wang H, Zhu D, et al. (2015) Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation. Proceedings of the National Academy of Sciences of the United States of America. 112: 1137-42
Xu H, Rahimpour S, Nesvick CL, et al. (2015) Activation of hypoxia signaling induces phenotypic transformation of glioma cells: Implications for bevacizumab antiangiogenic therapy Oncotarget. 6: 11882-11893
El-Amouri SS, Dai M, Han JF, et al. (2014) Normalization and improvement of CNS deficits in mice with hurler syndrome after long-term peripheral delivery of BBB-targeted iduronidase. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 2028-37
Mistry PK, Liu J, Sun L, et al. (2014) Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease. Proceedings of the National Academy of Sciences of the United States of America. 111: 4934-9
Dai M, Han J, El-Amouri SS, et al. (2014) Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome. Proceedings of the National Academy of Sciences of the United States of America. 111: 2680-5
Barranger JA, Brady RO, Grabowski GA, et al. (2014) Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014. American Journal of Hematology. 89: 457-8
Yang C, Swallows CL, Zhang C, et al. (2014) Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones. Proceedings of the National Academy of Sciences of the United States of America. 111: 249-54
Erba PA, Minichilli F, Giona F, et al. (2013) 99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with Gaucher disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1717-24
Lu J, Frerich JM, Turtzo LC, et al. (2013) Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury. Proceedings of the National Academy of Sciences of the United States of America. 110: 10747-52
See more...